Cyanvac

0 followers

‌

Cyanvac develops vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.

Industries

Biotechnology, Health Care

Headquarters

Athens, United States

Links

Org chart

Fred C. Davison

Chief Executive Officer

Collapse

Gary Titus

Chief Financial Officer

Hong Jin

Chief Scientific Officer

Marinka Tellier

Chief Regulatory Affairs Officer

Samuel Wu

Chief Business Officer

Teams

This company has no teams yet

Offices

HQ
3 people · 0 jobs

AtriCure

4 followers

Merck

341 followers

AbbVie

341 followers

Abbott

447 followers

Amgen

333 followers

Agiliti

9 followers

Elanco

37 followers

Taiho Oncology, Inc.

3 followers

Revvity

12 followers

DM Clinical Research

18 followers

Bristol-Myers Squibb

303 followers

Cyanvac

Org chart

Teams

Offices

Related companies